Recent advances in tumor immunotherapy based on NK cells
Immunotherapy has emerged as the established fourth pillar of cancer treatment following surgery, radiotherapy, and chemotherapy, representing a cutting-edge research domain in translational medicine and clinical oncology. Natural killer (NK) cells, a type of innate cytotoxic lymphocyte, possess uni...
Saved in:
| Main Authors: | Mengmeng Chen, Bing Zhang, Xuanlin Mu, Bingqiang Zhang, Tielin Yang, Gaofeng Zhang, Yuchao Gu, Bin Pei, Shaoshuai Liang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1595533/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity
by: Yuma Fukutani, et al.
Published: (2025-07-01) -
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances
by: Quinlan McLaughlin, et al.
Published: (2025-08-01) -
NK cells expansion <i>in vitro</i> is followed by loss of inhibitory KIR expression
by: N. A. Alekseeva, et al.
Published: (2023-06-01) -
Comprehensive characterization of NK cell-related genes in cutaneous melanoma identified a novel prognostic signature for predicting the prognosis, immunotherapy, and chemotherapy efficacy
by: Haili Ma, et al.
Published: (2025-07-01) -
Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1
by: Ildefonso Sánchez-Cerrillo, et al.
Published: (2025-06-01)